










































































































































































































































































































































































Biogenic	amines:	 	Histamine	 Vasodilation,	increase	vascular	permeability	and	pain	Serotonin	 Vasoconstriction	and	pain	
Enzymes:		 Remodel	tissue	matrix	Tryptase	 Degradation	of	fibrinogen,	pro-inflammatory,	pain	Chymase	 Degradation	of	basal	membrane	substance,	conversion	of	Angiotensin	Carboxypeptidase	A	 Peptide	processing	



























































Berberine	sulphate	 -	 +	 (Kitamura,	1989)	
Mediators	
Histamine	 <1	pg/	cell	 1-30	pg/cell	 (Purcell	et	al.,	1989)	









LTC4	 >25	ng/105	cells	 n.d	 (Razin	et	al.,	1982a)	
LTB4	 3-12	ng/105	cells	 n.d	 (Levi-Schaffer	et	al.,	1987)	
PGD2	 1-5	ng/105cells	 n.d	 (Levi-Schaffer	et	al.,	1987)	
Response	to	secrtagouges	
IgE/Ag	 +	 +	 (Kitamura,	1989)	(Galli,	1990)	
Substance	P	 +	 +	 (Kitamura,	1989)	(Galli,	1990)	











































































































Figure.1.4.	Mast	cell-	nerve	interaction.		Mast	cell-nerve	proximity	is	mediated	by	adhesion	molecules:	cell	adhesion	molecule-1	(CADM1)	and	N-cadherins.	 This	 proximity	 facilities	 the	 functional	 bidirectional	 communication.	 Mast	 cell	 releases	 or	synthesizes	mediators,	which	act	on	the	relevant	receptors	expressed	by	sensory	neurons.	Sensory	neuron	responses	by	release	neuropeptides	that	activate	mast	cells.	Encircles	numbers	represent	references.	(1)	(Linden	et	al.,	2001);	(2)	(Amadesi	et	al.,	2004);	(3)	(Leon	et	al.,	1994);	(4)	(Lindsay	and	Harmar,	1989);	




































































































































MEM	Vitamin	100X	 500	μl	 1%	 Gibco	11120-037	
2-mercaptoethanol	 50	μl	 50	μM	 Gibco	31350-010	
Sodium	pyruvate	100	mM	 500	μl	 1%	 Gibco	11360-039	
Non-essential	amino	acid	X100	 500	μl	 1%	 Gibco	11140-035		
Growth	Factors	Reagent	 Amount	 Concentration	 Supplier	
Mouse	SCF	10	μg/ml	 25	μl	 10	ng/ml	 R&D	systems	455-MC-010	















































Complete	NBA	Reagent		 Amount	 Concentration	 Supplier	
NBA	 10	ml	 	 Gibco	10888-022	
B-27	 200	μl	 2%	 Gibco	17504044	
Glutamax	200mM	 100	μl	 2	mM	 Gibco	35050-061	
Penicillin/Streptomycin	 100	μl	 1	%	 PAA	P11-013	
Ara-C	(1mM)	 10	μl	 1	μM	 Sigma	C1768		
Growth	Factors	Reagent		 Amount	 Concentration	 Supplier	














































































Reagent		 Amount	 Concentration	 Supplier	
Citric	acid	 2.34g	 0.2M	 Sigma,	C1909	
Na	Citrate	 2.588g	 0.2M	 BDH	301284C	
Autoclaved	ddH2O	 100	ml	 	 	





2.3.4	Measuring	cytokines	release	by	ELISA	(IL-6,	and	TNFα)	IL-6,	 and	 TNFα	 are	 cytokines	 important	 for	 both	 homeostatic	 and	 inflammatory	functions	 of	 mast	 cells.	 To	 prepare	 lysate	 for	 the	 assay,	 1X105	 BMMCs/well	 were	stimulated	with	DNP	for	6	hours	in	37°C.	Then,	cell	suspension	was	transferred	to	1.5	ml	




















	 Y = 0.003932*X - 0.05115
BMMC cell count (X103)
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Resolving	Gel	 10%	Water	 4.1	ml	Tris	pH	8.8	 2.5	ml	30%	Acrylamide	 3.3	ml	10%	sodium	dodecyl	sulphate	(SDS)	 100	µl	10%		Ammonium	Persulfate	(APS)	 50	µl	Tetramethylethylenediamine	(TEMED)	 10	µl	
Table	2.8	Resolving	gel		
































































































































































Figure	 3.3.	 In	 the	 short	 term,	 culturing	 BMMCs	 with	 SCF	 does	 not	 alter	 antigen-induced	
degranulation.	BMMCs	were	cultured	in	IL-3	in	the	presence	(cSCF-BMMC)	or	absence	of	SCF	(BMMC)	for	4	weeks.	The	cells	were	then	sensitized	with	IgE	overnight,	before	being	challenged	with	the	indicated	concentrations	of	Ag	(DNP)	for	30	minutes	and	b-hex	released	into	the	extracellular	medium	determined	and	expressed	as	a	percentage	of	the	total	cellular	content	of	b-hex.	Data	shown	are	mean	±	SEM	of	3	independent	experiments,	each	performed	in	duplicate.	Data	were	analyzed	using	two-tailed	paired	t-test.		



































































































































































Figure.	 4.1.	 Effect	 of	 Ara-C	 and	 serum-free	medium	 in	 controlling	 proliferation	 of	 non-neuronal	




























































































































































































































































































































































































































































































































































































































Figure.	4.9.	Effect	of	capsaicin-activated	sensory	neurons	on	BMMC	degranulation.		(A)	 Sensory	 neurons	 maintained	 for	 1-day	 in	 co-culture	 with	 BMMCs	 were	 activated	 with	 1µm	 of	Capsaicin	 for	 20	 minutes	 at	 37oC.	 Then,	 the	 percentage	 of	 β-hexosaminidase	 (β-Hex)	 release	 was	measured.	For	control,	β-Hex	release	was	also	measured	 from	DRG,	BMMC	and	capsaicin-activated	DRG	and	 BMMC	 (B)	 BMMCs	were	 cultured	 alone	 or	with	 supernatant	 from	 capsaicin-	 activated	 DRG	 for	 20	minutes.	 Then,	 β-hex	 release	 was	 measured.	 (C)	 Pre-sensitized	 BMMCs	 were	 cultured	 alone	 or	 with	supernatant	from	capsaicin	(Cap)-	activated	DRG	for	20	minutes.	Then,	β-hex	release	was	measured	after	activation	with	100ng/ml	DNP	for	30	minutes.	Total	β-hex	measured	from	BMMC	lysed	with	0.5%	Triton	X	l00.	Data	shown	are	mean	±	SEM	of	N=3,	each	performed	in	duplicate.	For	(A),	Data	were	analyzed	using	one-way	 ANOVA	 followed	 by	 Turkey’s	 multiple	 comparison	 post-test,	 while	 for	 (B	 and	 C)	 two-tailed	paired	t-test.	*	p<	0.05	and	**	p<	0.01	compared	to	appropriate	controls.	



















































































































































































































































































































































































































































































































































































































































































































































Multiple T-test ,Holm-Sidak method, with alpha=0.05.
ns
ns



























































































Figure.	7.1	Proposed	CADM1-	mediated	signaling	pathways	in	mast	cell.	CADM1	 can	 influence	 the	 activity	 of	 tyrosine	 kinase	 such	 as	 FYN/PLC	 signaling	 pathway	 and/	 or	may	interact	 with	 other	 receptor,	 such	 as	 kit,	 to	 influence	 IgE-mediated	 mast	 cell	 activation.	 The	 Figure	 is	modified	from	Figure	3.5				More	interestingly,	CAMs	can	also	modulate	receptor	tyrosine	kinases	signaling	within	a	single	cell	and	without	mediate	cell–cell	adhesion.	This	can	be	happened	by	different	mechanisms.	It	could	be	by	interacting	and	activating	growth	factor	receptors	and	other	signalling	proteins.	The	prototypical	example	that	is	extensively	studied	is	the	interaction	between	NCAM	and	fibroblast	growth	factor	receptor	(FGFR)	(Williams	et	al.,	1994)	(Francavilla	et	al.,	2007).	NCAM	directly	binds	to	FGFR	to	produce	a	distinctive	
signaling	cascade	from	those	produced	by	binding	of	its	ligand	fibroblast	growth	factor	(Francavilla	et	al.,	2009).	Moreover,	E-cadherin	binds	to	vascular	endothelial	growth	factor	receptor	2	(VEGFR2)	to	prevent	its	internalization	(Lampugnani	et	al.,	2006).	However,	cis	clustering	of	CAMs	that	follow	the	initiation	of	trans	cell-cell	adhesion	could	amplify	other	signaling	pathways.	Clustering	is	a	lateral	homotypic	binding	of	
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CAMs	on	cell	membrane	of	the	same	cell	to	strength	the	intercellular	adhesion.	As	a	result,	signaling	membrane	receptors	come	in	close	contact	with	their	cytoplasmic	partners	including	tyrosine	kinase	and	initiate	signaling.	Overall,	the	recognition	that	CAMs	not	only	maintain	cell-cell	adhesion	but	also	can	induce	intercellular	communications	and	signaling	supports	our	proposal	that	CADM1-mediated	adhesion	of	BMMC	to	neurons	has	important	functional	consequences.	Cell	signaling	driven	by	CADM1	in	BMMC	is	likely	to	enhance	FcɛRI	signaling.	Further	studies	are	required	to	fully	
understand	this	signaling	process.			Results	of	this	study	would	contribute	to	the	available	knowledge	about	mast	cell-	neuron	crosstalk	in	health	and	diseases.	In	fact,	studying	mast	cell-	neuron	crosstalk	in	GIT	is	of	great	interest	because	GIT	is	known	to	contain	the	most	extensive	immune	system	in	the	body,	as	well	as,	it	has	a	very	rich	supply	of	sensory	nerves.	This	anatomy	promotes	opportunity	for	nerves	that	release	neuropeptides	and	other	mediators	to	activate	mast	cells	that	nearby	(Stead	et	al.,	1989)	(Barbara	et	al.,	2004).	This	bidirectional	crosstalk	plays	a	homeostatic	unit	in	maintaining	gut	physiology	(section	1.1.5.1.1),	as	well	as	pathogenesis	of	GI	disorders	such	as	IBS.			The	contribution	of	mast	cell-nerve	interaction	in	the	pathogenesis	of	IBS	is	based	on	the	following	evidence:	(1)	an	increased	number	of	mast	cells	attached	to	nerves	in	IBS	patients	compare	to	controls	(Park	et	al.,	2003)	(Barbara	et	al.,	2004).	(2)	The	severity	and	the	frequency	of	abdominal	pain	in	IBS	patients	are	significantly	correlated	to	the	number	of	degranulated	mast	cells	in	direct	contact	to	nerves	(Barbara	et	al.,	2004)	(Park	et	al.,	2006).	(3)	The	severity	and	the	frequency	of	abdominal	pain	in	IBS	patients	are	also	significantly	correlated	with	expression	of	TRPV1	receptor	on	sensory	neurons	in	GIT	(Akbar	et	al.,	2008).	These	correlations	suggest	that	as	the	disease	gets	worse,	the	mast	cell-	nerve	interaction	got	stronger.	(4)	Finally	and	most	important	clinically,	mast	cell	stabilizers	have	been	shown	to	decrease	visceral	hypersensitivity	in	patient	with	IBS	(Klooker	et	al.,	2010).			
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However,	the	incidence	of	IBS	in	atopic	patients	with	known	history	of	conditions	such	as	asthma,	eczema,	or	atopic	rhinoconjunctivitis	is	higher	than	non-atopic	(Powell	et	al.,	2007)	(Tobin	et	al.,	2008b)	(Lillestøl	et	al.,	2010)	(Walker	et	al.,	2014).	Indeed,	a	cross-sectional	study	on	IBS	patients	showed	a	significant	correlation	between	serum	IgE	levels,	that	a	biomarker	for	allergies,	and	number	of	IgE-	positive	mast	cells	in	intestinal	biopsies	(Lillestøl	et	al.,	2010).	Interestingly,	IBS	symptoms	were	positively	associated	with	elevated	serum	IgE	levels	(Vara	et	al.,	2016).	Thus,	atopic	IBS	has	been	defined	as	development	of	IBS	in	atopic	patients	(Tobin	et	al.,	2008a).			These	literatures	indicate	that	the	more	severe	atopic	disease	the	stronger	mast	cell-neuron	crosstalk.	In	the	light	of	my	data,	I	propose	an	explanation	for	these	observations.	In	atopic	patients	with	high	level	of	serum	IgE,	the	exposure	to	Ag,	likely	from	ingested	food,	activates	IgE-positive	mast	cells	in	the	gut.	The	attachment	of	mucosal	mast	cells	to	neurons,	presumably	mediated	by	CADM1,	enhances	the	IgE	–	mediated	mast	cells	mediators	release	that	induce	visceral	hypersensitivity.	Consequently,	symptoms	of	IBS	would	get	worse.			This	explanation	could	be	completely	applicable	on	all	mast	cell-	neuron	interactions	in	different	tissue.	In	fact,	it	has	been	suggested	that	allergen-induced	neuromodulation	resulted	in	hyperactivity	of	nervous	system	in	atopic	patients	(Undem	and	Taylor-Clark,	2014).	As	capsaicin	induces	strong	parasympathatic	reflex	and	sneezing	when	applied	to	nasal	mucosa	of	atopic	rhinitis	patients,	an	effect	that	is	not	seen	in	healthy	subjects	(Sarin	et	al.,	2006).		All	these	data	emphasize	the	principal	role	of	IgE-mediated	mast	cell	activation	on	neuronal	activity.	An	interesting	question	is	whether	manipulation	of	this	pathway	lead	to	a	substantial	improvement	in	neuronal-	related	symptoms.	Different	potential	agents	targeting	mast	cell	biology	has	been	proposed	(Zhang	et	al.,	2016).	Among	them,	Omalizumab.	Omalizumab	stabilizes	mast	cell	functions	by	neutralizing	soluble	IgE	as	well	as	downregulating	surface	FcɛRI	on	mast	cells.	It	is	known	for	it	is	high	efficacy	in	controlling	moderate	to	severe	asthma	(Society	and	Network,	2014).	In	addition,	it	has	shown	its	effectiveness	in	treatment	of	other	allergic	diseases	as	rhinitis	
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(Casale	et	al.,	2001),	atopic	dermatitis	(Lane	et	al.,	2006)	and	urticaria	(Maurer	et	al.,	2013).	It	was	reported	in	case	study	that	it	showed	a	promising	effect	in	complete	resolution	of	IBS	symptoms	in	patient	on	Omalizumab	for	other	atopic	diseases	(Pearson	et	al.,	2015).	Possible	future	experiments	using	co-culture	model	in	the	same	way	of	this	
thesis	could	be	used	to	test	the	effect	of	different	mast	cell-targeting	approach	on	attenuate	
mast	cell-neuron	communication.			
	
Another	interesting	avenue	for	future	investigation	would	be	detailed	exploring	the	
underling	signaling	of	CADM1-dependent	neuronal	enhancement	on	IgE-mediated	
activation	in	mast	cells.	Structurally,	CADM1	resembles	NCAM,	both	belong	to	the	immunoglobulin	superfamily.	As	I	discussed	above,	NCAM	has	been	showed	to	induce	intracellular	signaling	and	interact	with	growth	factor	receptors.	Therefore,	there	is	a	possibility	that	CADM1	share	the	same	FYN/MAPK	signaling	pathway	and	may	interact	with	other	receptor	to	enhance	IgE-mediated	mast	cell	activation.	Analysis	of	FceRI	signaling	in	co-cultures	from	CADM1	knockdown	BMMCs	could	shed	some	light	onto	potential	regulatory	mechanism	of	CADM1	in	mast	cell	activity.	A	basic	technique	to	study	the	activity	of	different	kinase	that	may	involve	in	this	signal	transduction	could	be	measured	by	kinase	assay.	In	addition,	protein-protein	interactions	within	the	pathway	could	be	studied	by	co-immunoprecipitation	technique	(Kawakami	and	Kawakami,	2015).		
	This	study	addressed	the	regulatory	role	of	CADM1	in	mast	cells	activation	in	vitro,	however,	these	results	need	to	be	verified	in	vivo	in	order	to	determine	the	role	of	CADM1	in	health	and	diseases.	To	do	so,	mast	cell-	deficient	mice	that	has	been	engrafted	with	CADM1-knockdown	BMMCs	could	be	used.	Although	mast	cell-	deficient	kitW/kitWv	and	kitW-sh/kitW-sh	mice	has	been	used	extensively	for	this	purpose,	the	kit-mutation	can	confound	the	results	from	these	mouse	models(Kakurai	et	al.,	2006).	Therefore,	a	new	mast	cell-	deficient	mouse	model	has	been	introduced.	The	mast	cell-deficient	in	these	mice	is	as	a	result	of	ablation	of	myeloid	cell	leukemia	1	(Mcl-1)	which	known	as	anti-apoptotic	factor.	Consequently,	C57BL/6-Cpa3-Cre+-Mcl-1fl/fl		mice	with	normal	kit	are	produced	which	are	called	informally	“Hello	Kitty”	mice	(Lilla	et	al.,	
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2011).	Such	models	have	been	extremely	useful	in	assessing	the	role	of	CADM1	in	mast	cell-related	disorders	in	general,	and	in	neurogenic	inflammatory	disorders	in	specific.		Furthermore,	it	can	be	useful	to	assess	whether	the	absence	of	CADM1-	mediated	mast	cell	adhesion	to	neurons	has	adverse	effects	on	the	whole	organism	health.	However,	before	translate	these	results	to	human,	it	is	important	to	compare	this	data	to	other	mast	cells	phenotype	because	of	mast	cell	heterogeneity	is	a	critical	issue	in	mast	cell	biology.		
	Another	issues	that	could	limit	my	data	and	remain	to	be	addressed	are:	(1)	Among	wide	range	of	mast	cell	cytokines,	only	IL-6	and	TNFa	were	measured.	Furthermore,	a	single	granule	component,	β-hexosaminidase	was	measured	for	assessment	of	the	level	of	degranulation.	However,	other	mast	cell	and	neuronal	mediators	such	as	neuropeptides,	ATP,	serotonin	and	PGD2	are	known	to	intimately	involved	in	the	crosstalk.	Therefore,	these	mediators	must	be	investigated	in	depth	in	order	to	final	understand	the	extend	of	mast	cell-	neuron	interactions	in	health	and	the	diseases.	(2)		Although	I	have	shown	that	neurons	express	CADM1,	future	studies	should	carry	out	to	comprehensive	investigate	CADM1	distribution	along	the	neurites	and	weather	it	is	in	random	fashion	or	its	at	particular	spots,	presumably,	in	co-localization	with	receptors	that	involve	in	crosstalk.	Moreover,	I	didn’t	test	the	contribution	of	CADM1	expressed	by	DRG	on	the	enhancement	of	mast	cell	function	in	co-culture.	The	difficulty	of	transfection	primary	neurons	is	the	major	cause.	However,	this	could	represent	the	objective	of	future	studies.	
	
In	summary,	my	data	support	the	concept	that	mast	cells	responsiveness	could	be	influenced	by	their	interaction	with	other	cells	such	as	neurons.		Cell	signaling	mediated	by	CADM1	is	a	fundamental	process	to	regulate	mast	cell-	neuron	crosstalk	that	is	believed	to	be	important	in	the	progression	of	many	disorders	related	to	neurogenic	inflammation.			
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